腹主动脉瘤腔内治疗的问题与研究进展  

Progress in endovascular treatment of abdominal aortic aneurysm

作　　者：梁宏伟 陈贵俦 叶旭明 LIANG Hongwei;CHEN Guichou;YE Xuming(Department of vascular and thyroid hernia,Yangjiang people’s Hospital,Yangjiang,Guangdong 529500,China)

机构地区：[1]阳江市人民医院血管甲状腺疝科,广东阳江529500

出　　处：《医药前沿》2022年第22期47-49,共3页Journal of Frontiers of Medicine

摘　　要：腹主动脉瘤主要是指腹主动脉壁的病变或者损伤形成局限性的膨出,其主要临床症状为搏动性的肿块。大部分腹主动脉瘤是由于动脉粥样硬化所引起,少数可以由于创伤或者感染而形成腹主动脉瘤,以高龄的男性较为常见,常常发生在腹主动脉的各个部位。近年来,腹主动脉瘤发病率不断增加,腔内治疗具有恢复快、术后并发症少、创伤小等特点,被广泛应用于临床。本文就腹主动脉瘤腔内治疗的问题与研究进展进行综述。The incidence rate of abdominal aortic aneurysm is increasing,which mainly refers to the localized bulge caused by the lesion or injury of the abdominal aortic wall.In clinical practice,the main clinical symptom of patients with abdominal aortic aneurysm is pulsatile mass.Most abdominal aortic aneurysms are caused by atherosclerosis,and a few can form abdominal aortic aneurysms due to trauma or infection.It is more common in elderly men and often occurs in various parts of the abdominal aorta.Endovascular therapy is widely used in clinical practice.It has the characteristics of rapid recovery,less postoperative complications and less trauma.It is widely used in clinical practice.With the completion of more and more randomized controlled trials,Results it can guide clinical practice more accurately.

关 键 词：综述 腹主动脉瘤 腔内治疗 进展 

分 类 号：R543.1[医药卫生—心血管疾病]